HLA DQA1∗05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children with Crohn's Disease

Jeremy Adler*, Joseph A. Galanko, Rana Ammoury, Keith J. Benkov, Athos Bousvaros, Brendan Boyle, José M. Cabrera, Kelly Y. Chun, Jill Dorsey, Dawn R. Ebach, Ann M. Firestine, Ajay S. Gulati, Hans H. Herfarth, Traci W. Jester, Jess L. Kaplan, Ian Leibowitz, Tiffany M. Linville, Peter A. Margolis, Phillip Minar, Zarela Molle-RiosJonathan Moses, Kelly Olano, Dinesh S. Pashankar, Lisa Pitch, Shehzad A. Saeed, Charles M. Samson, Kelly Sandberg, Steven J. Steiner, Jennifer A. Strople, Jillian S. Sullivan, Prateek D. Wali, Michael D. Kappelman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'HLA DQA1∗05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children with Crohn's Disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry